Literature DB >> 14976477

Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma.

Jürgen Weitz1, Michael D'Angelica, William Jarnagin, Mithat Gonen, Yuman Fong, Leslie Blumgart, Ronald Dematteo.   

Abstract

BACKGROUND: Patients with hepatocellular carcinoma (HCC) are frequently found to be inoperable at surgical exploration. Laparoscopy may reduce the rate of unnecessary laparotomy in these patients. However, there are no criteria for selective use of laparoscopy.
METHODS: Sixty patients with potentially operable HCC underwent laparoscopy prior to planned partial hepatectomy. Intraoperative findings and postoperative course were analyzed, and factors for the selective use of laparoscopy were identified.
RESULTS: Fourteen of 19 inoperable patients (74%) were identified by means of laparoscopy, which increased the resectability rate from 68% to 89%. Compared with patients undergoing exploratory laparotomy only, patients determined to be inoperable on laparoscopy had significantly less intraoperative blood loss, a shorter operating room time, and a briefer hospital stay. In a multivariate analysis, clinically apparent liver cirrhosis and radiologic evidence of major vascular invasion or bilobar tumors predicted the likelihood of finding inoperable disease at laparoscopy. The initial use of laparoscopy avoided unnecessary laparotomy in almost 30% of patients with-but only 5% of patients without-these features.
CONCLUSIONS: If high-risk patients with HCC are selectively targeted, the yield of laparoscopy is increased and unnecessary laparotomy may be avoided. In patients without cirrhosis, major vascular invasion, or bilobar tumors, the yield of laparoscopy is low and is therefore not generally recommended.

Entities:  

Mesh:

Year:  2004        PMID: 14976477     DOI: 10.1016/j.surg.2003.07.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Laparoscopic staging for hepatobiliary carcinoma.

Authors:  Rebekah R White; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

2.  Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy.

Authors:  Sebastien Gaujoux; Peter J Allen
Journal:  World J Gastrointest Surg       Date:  2010-09-27

Review 3.  Management of hepatocellular carcinoma.

Authors:  Janice N Cormier; K Tyson Thomas; Ravi S Chari; C Wright Pinson
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

4.  Diagnostic laparoscopy in the evaluation of the viral hepatitis patient with potentially resectable hepatocellular carcinoma.

Authors:  Eunjie K Klegar; Stuart G Marcus; Elliot Newman; Spiros P Hiotis
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

5.  Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; David P Eisenberg; Zhenkun Yu; Stephen F Stanziale; Rumana Huq; Richard J Wong; Valerie W Rusch; Yuman Fong
Journal:  FASEB J       Date:  2006-02-08       Impact factor: 5.191

6.  Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours.

Authors:  Raneem Albazaz; Chirag N Patel; Fahmid U Chowdhury; Andrew F Scarsbrook
Journal:  Insights Imaging       Date:  2013-07-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.